Process View
Any process that modulates the activity of the enzyme nitric-oxide synthase.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of nitric oxide synthase activity"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
Lepr | leptin receptor | 0.972 | ||
Nos3 | nitric oxide synthase 3, endothelial cell | 0.601 | ||
Pparg | peroxisome proliferator activated receptor gamma | 0.579 | ||
Nos1 | nitric oxide synthase 1, neuronal | 0.539 | ||
Tgfbr2 | transforming growth factor, beta receptor II | 0.379 | ||
Tgfb1 | transforming growth factor, beta 1 | 0.265 | ||
Lep | leptin | 0.217 | ||
Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 0.151 | ||
Ghr | growth hormone receptor | 0.091 | ||
Ren1 | renin 1 structural | 0.074 | ||
Agtr1a | angiotensin II receptor, type 1a | 0.065 | Mouse | |
Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.060 | ||
Smad4 | MAD homolog 4 (Drosophila) | 0.056 | ||
Fshr | follicle stimulating hormone receptor | 0.055 | ||
Lrp1 | low density lipoprotein receptor-related protein 1 | 0.054 | ||
Ldlr | low density lipoprotein receptor | 0.049 | ||
Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.046 | ||
Gnas | GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus | 0.040 | ||
Pten | phosphatase and tensin homolog | 0.037 | ||
Ntrk2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.037 | ||
Ace | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.037 | ||
Ppargc1a | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | 0.034 | ||
Kit | kit oncogene | 0.032 | ||
Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.031 | ||
Nodal | nodal | 0.030 | ||
Src | Rous sarcoma oncogene | 0.028 | ||
Asap1 | ArfGAP with SH# domain, ankyrin repeat and PH domain1 | 0.026 | ||
Smad3 | MAD homolog 3 (Drosophila) | 0.025 | ||
Bcar1 | breast cancer anti-estrogen resistance 1 | 0.025 | ||
Vdr | vitamin D receptor | 0.024 | ||
Dmd | dystrophin, muscular dystrophy | 0.024 | ||
Nos2 | nitric oxide synthase 2, inducible | 0.024 | ||
Ar | androgen receptor | 0.023 | ||
Pgr | progesterone receptor | 0.023 | ||
Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.022 | ||
Npy1r | neuropeptide Y receptor Y1 | 0.022 | ||
Ptrf | polymerase I and transcript release factor | 0.021 | ||
Acvrl1 | activin A receptor, type II-like 1 | 0.019 | ||
Cav1 | caveolin 1, caveolae protein | 0.019 | ||
Esr2 | estrogen receptor 2 (beta) | 0.018 | ||
Apc | adenomatosis polyposis coli | 0.017 | ||
Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | 0.016 | ||
Agtrap | angiotensin II, type I receptor-associated protein | 0.015 | ||
Clcn5 | chloride channel 5 | 0.015 | ||
Npc1 | Niemann Pick type C1 | 0.015 | ||
Grin1 | glutamate receptor, ionotropic, NMDA1 (zeta 1) | 0.014 | ||
Mstn | myostatin | 0.013 | ||
Prkce | protein kinase C, epsilon | 0.013 | ||
Hif1a | hypoxia inducible factor 1, alpha subunit | 0.013 | ||
Efemp2 | epidermal growth factor-containing fibulin-like extracellular matrix protein 2 | 0.013 | ||
Insr | insulin receptor | 0.013 | ||
Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.011 | ||
Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 0.011 | ||
Esr1 | estrogen receptor 1 (alpha) | 0.011 | Human | |
Igf1 | insulin-like growth factor 1 | 0.010 | ||
Smad2 | MAD homolog 2 (Drosophila) | 0.010 | ||
Tlr2 | toll-like receptor 2 | 0.010 |